QC
LMAT icon

Quadrature Capital’s LeMaitre Vascular LMAT Stock Holding History

Quadrature Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,020
Closed -$281K – 1250
2024
Q3 		$281K Buy
+3,020
New +$262K 0.01% 670
2024
Q2 		– Sell
-22,432
Closed -$1.48M – 1356
2024
Q1 		$1.48M Buy
22,432
+12,654
+129% +$781K 0.03% 370
2023
Q4 		$555K Sell
9,778
-1,911
-16% -$100K 0.01% 635
2023
Q3 		$638K Sell
11,689
-4,604
-28% -$273K 0.01% 532
2023
Q2 		$1.1M Buy
+16,293
New +$994K 0.02% 413
2022
Q1 		– Sell
-4,816
Closed -$242K – 855
2021
Q4 		$242K Buy
+4,816
New +$249K 0.01% 537
2021
Q3 		– Sell
-7,945
Closed -$485K – 880
2021
Q2 		$485K Buy
+7,945
New +$422K 0.02% 504
2021
Q1 		– Sell
-26,752
Closed -$1.08M – 1029
2020
Q4 		$1.08M Buy
+26,752
New +$956K 0.05% 286

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrature Capital's LMAT Position: Q4 2024 in Review

Quadrature Capital sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 3,020 shares — an estimated $281K sold.

Quadrature Capital first reported a position in LMAT in Q4 2020 and held it in 8 quarters. The position peaked at $1.48M in Q1 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

  • Quadrature Capital reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
  • Quadrature Capital sold 3,020 LeMaitre Vascular shares in Q4 2024, an estimated $281K.
  • Quadrature Capital first reported a position in LeMaitre Vascular in Q4 2020 and held it in 8 quarters.
  • Quadrature Capital's LeMaitre Vascular position peaked at $1.48M in Q1 2024.
  • 307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Quadrature Capital's 13F filing for Q4 2024, filed 13 Feb 2025.